Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 2
2012 5
2013 4
2014 2
2015 3
2016 2
2018 1
2019 3
2020 4
2021 4
2022 6
2023 5
2024 5
2025 8
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study.
Akdeniz N, Kaplan MA, Uncu D, İnanç M, Kaya S, Dane F, Küçüköner M, Demirci A, Bilici M, Durnalı AG, Koral L, Şendur MAN, Erol C, Türkmen E, Ölmez ÖF, Açıkgöz Ö, Laçin Ş, Şahinli H, Urakçı Z, Işıkdoğan A. Akdeniz N, et al. Among authors: kaplan ma. Int J Colorectal Dis. 2021 Jun;36(6):1311-1319. doi: 10.1007/s00384-021-03888-9. Epub 2021 Feb 14. Int J Colorectal Dis. 2021. PMID: 33586012
Comparison of inflammatory indices in patients with metastatic non-small cell lung cancer.
Urakçı Z, Oruc Z, Kömek H, Ebinç S, Pirinççi E, Kalkan Z, Taşdemir B, Kaplan MA, Küçüköner M, Işıkdoğan A. Urakçı Z, et al. Among authors: kaplan ma. Rev Assoc Med Bras (1992). 2025 Jun 2;71(4):e20240411. doi: 10.1590/1806-9282.20240411. eCollection 2025. Rev Assoc Med Bras (1992). 2025. PMID: 40465984 Free PMC article.
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group.
Telli TA, Tatlı AM, Alan Ö, Keskin GY, Karadurmuş N, Karakaya S, Kaplan MA, Açıkgöz Ö, Bilici A, Mocan EE, Demirkazık A, Kahraman S, Şendur MA, Doğan M, Selam MT, Er Ö, Ünsal O, Yazıcı O, Özcan E, Kargı A, Gürbüz M, Selçukbiricik F, Şakalar T, Gürsoy P, Bilgin B, Selvi O, Karadağ İ, Eren OÖ, Bayram E, Sümbül AT, Keskin S, Öztürk A, Topçu S, Özen M, Kılıçkap S, Yumuk PF. Telli TA, et al. Among authors: kaplan ma. Clin Lung Cancer. 2025 Dec;26(8):e649-e659. doi: 10.1016/j.cllc.2025.07.015. Epub 2025 Jul 22. Clin Lung Cancer. 2025. PMID: 40813186
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma.
Yildirim HC, Bayram E, Chalabiyev E, Majidova N, Avci T, Güzel HG, Kapar C, Uzun M, Perkin P, Akgül F, Yildirim SS, Sali S, Yildiz A, Kazaz SN, Hendem E, Arcagok M, Tufan G, Yildirim U, Akgul OF, Arslan Ç, Taban H, Sahin E, Caglayan M, Esen R, Öksüzoğlu B, Guven DC, Kaplan MA, Araz M, Basaran M, Cubukcu E, Gokmen E, Cicin I, Algin E, Semiz HS, Tural D, Ozturk B, Erdogan AP, Sari M, Kara O, Erman M. Yildirim HC, et al. Among authors: kaplan ma. J Chemother. 2025 Oct;37(6):551-562. doi: 10.1080/1120009X.2024.2403051. Epub 2024 Sep 10. J Chemother. 2025. PMID: 39257075
51 results